The Dividend Yield as of November 2024 (TTM) for Keros Therapeutics, Inc. (KROS) is 0%

According to Keros Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Keros Therapeutics, Inc. (KROS) Historical Dividend Yield (quarterly & annually)

How has KROS Dividend Yield performed in the past?

The mean historical Dividend Yield of Keros Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), KROS's Dividend Yield was at its highest in in the March 2019 quarter at 0%. The Dividend Yield was at its lowest in in the March 2019 quarter at 0%.

Keros Therapeutics, Inc. (KROS) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Keros Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Keros Therapeutics, Inc. (KROS) Average Dividend Yield

How has KROS Dividend Yield performed in the past?

The current Dividend Yield of Keros Therapeutics, Inc. (KROS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Keros Therapeutics, Inc. (KROS) Dividend Yield vs. Peers

How is KROS’s Dividend Yield compared to its peers?

Keros Therapeutics, Inc.’s Dividend Yield is less than IDEAYA Biosciences, Inc. (0%), less than AnaptysBio, Inc. (0%), less than MeiraGTx Holdings plc (0%), less than Homology Medicines, Inc. (0%), less than Janux Therapeutics, Inc. (0%), less than Fennec Pharmaceuticals Inc. (0%), less than Edgewise Therapeutics, Inc. (0%), less than Harmony Biosciences Holdings, Inc. (0%), less than Aerovate Therapeutics, Inc. (0%), less than Syndax Pharmaceuticals, Inc. (0%), less than Mineralys Therapeutics, Inc. (0%), less than Replimune Group, Inc. (0%), less than Erasca, Inc. (0%), less than Century Therapeutics, Inc. (0%), less than NGM Biopharmaceuticals, Inc. (0%), less than Monte Rosa Therapeutics, Inc. (0%), less than Surrozen, Inc. (0%), less than Bolt Biotherapeutics, Inc. (0%), less than Larimar Therapeutics, Inc. (0%), less than Kezar Life Sciences, Inc. (0%),

Build a custom stock screener for Keros Therapeutics, Inc. (KROS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Keros Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Keros Therapeutics, Inc. (KROS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Keros Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.